Silence Therapeutics plc SEC filings SLNCF
Silence Therapeutics plc has 275 filings in SEC EDGAR's recent list, going back to Jan 5, 2010. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, regulation fd disclosure).
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 27, 2026 | — |
| CORRESP | Letter to the SEC | May 22, 2026 | — |
| UPLOAD | Letter from the SEC | May 22, 2026 | — |
| UPLOAD | Letter from the SEC | Jan 9, 2026 | — |
| CORRESP | Letter to the SEC | Dec 31, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 18, 2025 | — |
| EFFECT | Filing | May 14, 2024 | — |
| CORRESP | Letter to the SEC | May 10, 2024 | — |
| UPLOAD | Letter from the SEC | May 10, 2024 | — |
| DEL AM | Filing | May 8, 2024 | — |
| EFFECT | Filing | Oct 22, 2021 | — |
| EFFECT | Filing | Oct 20, 2021 | — |
| EFFECT | Filing | Oct 20, 2021 | — |
| CORRESP | Letter to the SEC | Oct 20, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 20, 2021 | — |
| EFFECT | Filing | Apr 8, 2021 | — |
| EFFECT | Filing | Apr 8, 2021 | — |
| EFFECT | Filing | Mar 12, 2021 | — |
| CORRESP | Letter to the SEC | Mar 11, 2021 | — |
| UPLOAD | Letter from the SEC | Mar 9, 2021 | — |
| D | Filing | Feb 18, 2021 | — |
| EFFECT | Filing | Oct 2, 2020 | — |
| CERT | Filing | Sep 8, 2020 | — |
| SEC STAFF LETTER | Filing | Sep 4, 2020 | — |
| EFFECT | Filing | Sep 4, 2020 | — |
| 8-A12B | Filing | Sep 2, 2020 | — |
| CORRESP | Letter to the SEC | Sep 2, 2020 | — |
| CORRESP | Letter to the SEC | Aug 20, 2020 | — |
| SEC STAFF LETTER | Filing | Aug 18, 2020 | — |
| UPLOAD | Letter from the SEC | Aug 10, 2020 | — |
| DRSLTR | Filing | Jul 31, 2020 | — |
| DRS/A | Filing | Jul 31, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2020 | — |
| DRS | Filing | Jun 22, 2020 | — |
| D | Filing | Jan 5, 2010 | — |
| D | Filing | Jan 5, 2010 | — |
| D | Filing | Jan 5, 2010 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SLN (Nasdaq), SLNCF (OTC)
- Incorporated in
- United Kingdom
- Headquarters
- London
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1479615
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.